Chang‐Fang Chiu

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Nanomedicine, Oncology, Pancreatic Cancer +8

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Masatoshi Kudo, Ann‐Lii Cheng, Joong‐Won Park et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 189 citations

Hepatology, Medicine, Transcatheter Arterial Chemoembolisation +9

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Thomas Yau, Peter R. Galle, Thomas Decaens et al. · The Lancet · 2025 · 144 citations · Full text

Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.

Peter R. Galle, Thomas Decaens, Masatoshi Kudo et al. · Journal of Clinical Oncology · 2024 · 139 citations

Checkmate 9Dw, Pathology, Pharmacotherapy +21

Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhage

Ming‐Chih Chang, Tsai‐Yun Chen, Jih‐Luh Tang et al. · American Journal of Hematology · 2007 · 95 citations · Full text

Cranial Irradiation, Hematological Malignancy, Intracranial Hemorrhage +15